Corneal pathologic condition Vectors tested Genetic material Model Delivery route Effect on pathology resolution
Graft rejection AV, plasmids Cytotoxic T lymphocyte associated antigen 4, Inducible T-cell co-stimulator, Interleukin (IL)-10 antagonist, Interleukin-4 Mice, Rat, Sheep, Ex vivo IV, IP, Gene-gun +/-
Wound healing AV, AAV, retrovirus, Nanoparticles Decorin, Soluble type II TGFβ receptor, Tissue plasminogen activator Mice, Rat, Rabbit, Ex vivo, In vitro IM, Topical, Intrastromal, Intracameral, Electroporation +, +/-, -
Chemical burn AV, AAV, plasmids Decorin, SMAD7, Peroxisome proliferator activated receptor γ Mice, Rabbit Topical +, +/-
Haze and Fibrosis AV, AAV, plasmids, retrovirus. Nanoparticles Decorin, SMAD7, Peroxisome proliferator activated receptor γ, Soluble type II TGFβ receptor, BMP7, Herpes simplex virus thymidine kinase, Dominant negative cyclin G1 Rabbit, Ex vivo, In vitro Topical +, +/-, -
Neovascularization AV, AAV, plasmids, lentivirus Decorin, Vascular endothelial growth factor elated FLT-1, FLT23K, FLT24K, Endostsin, Kringle 5 plasminogen, Angistatin, IL-2, IL-10 Mice, Rat, Rabbit, Monkey, In vitro IM, Topical, Intrastromal, Intracameral, Electroporation +, +/-, -
Table2: Summary of corneal gene therapy research with potential application in veterinary ophthalmology.